Case report: B7-H3 CAR-T therapy partially controls tumor growth in a basal cell carcinoma patient

B7-H3 is over-expressed in multiple types of solid tumors, making it an ideal target for chimeric antigen receptor (CAR)-T therapy. Here, we first report a case of multiple basal cell carcinoma (BCC) patient treated with humanized monoclonal anti-B7-H3 CAR-T cells through direct intratumoral injecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Gang, Li, Guangchao, Wen, Wei, Ding, Wen, Zhou, Zhao, Zheng, Yongwei, Huang, Taoyuan, Ren, Junnan, Chen, Rongyi, Zhu, Dingheng, He, Renliang, Liang, Yunsheng, Luo, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428555/
https://www.ncbi.nlm.nih.gov/pubmed/36059640
http://dx.doi.org/10.3389/fonc.2022.956593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428555/
https://www.ncbi.nlm.nih.gov/pubmed/36059640
http://dx.doi.org/10.3389/fonc.2022.956593

Ejemplares similares